Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Christoph Hasslacher
Correction To: Intravenous Ferric Carboxymaltose in Patients With Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Intravenous Ferric Carboxymaltose for Heart Failure With Iron Deficiency
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Treatment of Iron Deficiency and Iron Deficiency Anemia With Intravenous Ferric Carboxymaltose in Pregnancy
Archives of Gynecology and Obstetrics
Medicine
Gynecology
Obstetrics
Anaphylaxis to Intravenous Ferric Carboxymaltose
Journal of the Korean Neurological Association
Treatment of Iron Deficiency With or Without Anaemia With Intravenous Ferric Carboxymaltose in Gynaecological Practices – A Non-Interventional Study
Geburtshilfe und Frauenheilkunde
Gynecology
Midwifery
Maternity
Obstetrics
Efficacy and Tolerability of Intravenous Ferric Carboxymaltose in Patients With Iron Deficiency at a Hospital Outpatient Clinic: A Retrospective Cohort Study of Real-World Clinical Practice
Anemia
Hematology
Cell Biology
Safety and Efficacy of Ferric Carboxymaltose in Children and Adolescents With Iron Deficiency Anemia
Journal of Pediatrics
Child Health
Pediatrics
Perinatology
Association Between Obesity and Depression in Patients With Diabetes Mellitus Type 2; A Study Protocol
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
A Comment on the Comparative Safety of Intravenous Ferumoxytol Versus Ferric Carboxymaltose in Iron Deficiency Anemia
American Journal of Hematology
Hematology
Is an Additional Dose of Intravenous Ferric Carboxymaltose Useful in the Treatment of Iron Deficiency Anemia?
International Journal of Blood Research and Disorders
